Live Breaking News & Updates on Division Of Transplantation Surgery At Massachusetts

Stay updated with breaking news from Division of transplantation surgery at massachusetts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TransMedics Announces Publication of OCS™ Liver PROTECT Trial Results in JAMA Surgery

/PRNewswire/ TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients. ....

United States , Waleed Hassanein , Jamesf Markmann , Brian Johnston , Transmedics Group Inc , Drug Administration , Journal Of The American Medical Association , Prnewswire Transmedics Group Inc , Division Of Transplantation Surgery At Massachusetts , Exchange Commission , European Union , Medics Group , American Medical Association , Liver Transplant , Liver System , Transplantation Surgery , Massachusetts General Hospital , Chief Executive , Transmedics Group , Health Care Amp Hospitals , Medical Pharmaceuticals , Medical Equipment , Clinical Trials Amp Medical Discoveries ,

TransMedics Announces Publication of OCS™ Liver PROTECT Trial Results in JAMA Surgery

/PRNewswire/ TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients. ....

United States , Waleed Hassanein , Jamesf Markmann , Brian Johnston , Transmedics Group Inc , Drug Administration , Journal Of The American Medical Association , Prnewswire Transmedics Group Inc , Division Of Transplantation Surgery At Massachusetts , Exchange Commission , European Union , Medics Group , American Medical Association , Liver Transplant , Liver System , Transplantation Surgery , Massachusetts General Hospital , Chief Executive , Transmedics Group ,

TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System

TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System
Panel votes unanimously in support of the OCS Liver System s safety and effectiveness
News provided by
Share this article
Share this article
ANDOVER, Mass., July 14, 2021 /PRNewswire/ TransMedics Group, Inc. ( TransMedics ) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that after review and discussion of TransMedics clinical evidence from the OCS Liver PROTECT trial, the Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee convened by the U.S. Food and Drug Administration ( FDA ) has issued a favorable vote in support of approval of the OCS Liver System. ....

United States , Waleed Hassanein , Jamesf Markmann , Transmedics Group Inc , Drug Administration , Advisory Committee , Division Of Transplantation Surgery At Massachusetts , Transmedics Group , Urology Devices Panel , Medical Devices Advisory Committee , Chief Executive , Transmedics Liver , Transplantation Surgery , Massachusetts General Hospital , System Device Advisory Panel , ஒன்றுபட்டது மாநிலங்களில் , வாலீட் ஹஸ்ஸனேன் , தலைமை நிர்வாகி , மாற்று அறுவை சிகிச்சை அறுவை சிகிச்சை , மாசசூசெட்ஸ் ஜநரல் மருத்துவமனை ,